The Current State of Knowledge of Hepatic Ischemia-Reperfusion Injury Based on Its Study in Experimental Models

The present review focuses on the numerous experimental models used to study the complexity of hepatic ischemia/reperfusion (I/R) injury. Although experimental models of hepatic I/R injury represent a compromise between the clinical reality and experimental simplification, the clinical transfer of experimental results is problematic because of anatomical and physiological differences and the inevitable simplification of experimental work. In this review, the strengths and limitations of the various models of hepatic I/R are discussed. Several strategies to protect the liver from I/R injury have been developed in animal models and, some of these, might find their way into clinical practice. We also attempt to highlight the fact that the mechanisms responsible for hepatic I/R injury depend on the experimental model used, and therefore the therapeutic strategies also differ according to the model used. Thus, the choice of model must therefore be adapted to the clinical question being answered.

[1]  R. Bartrons,et al.  Hepatic preconditioning preserves energy metabolism during sustained ischemia. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[2]  J. Ludwig,et al.  Hepatic steatosis as a potential risk factor for major hepatic resection , 1998, Journal of Gastrointestinal Surgery.

[3]  B. Koneru,et al.  Ischemic preconditioning of the liver: A few perspectives from the bench to bedside translation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  M. Marí,et al.  Critical role of acidic sphingomyelinase in murine hepatic ischemia‐reperfusion injury , 2006, Hepatology.

[5]  A. Blakemore,et al.  THE TECHNIC OF USING VITALLIUM TUBES IN ESTABLISHING PORTACAVAL SHUNTS FOR PORTAL HYPERTENSION , 1945, Annals of surgery.

[6]  D. Wight,et al.  SUCCESSFUL 48‐HOUR PRESERVATION OF THE RAT LIVER BY CONTINUOUS HYPOTHERMIC PERFUSION WITH HAEMACCEL‐ISOTONIC CITRATE SOLUTION , 1987, Transplantation.

[7]  K. Raivio,et al.  Circulating xanthine oxidase and neutrophil activation during human liver transplantation. , 1998, Gastroenterology.

[8]  I. Chaudry,et al.  Restoration of hepatocellular function and blood flow following hepatic ischemia with ATP-MgCl2. , 1982, Advances in shock research.

[9]  Y. Fujino Two-layer cold storage method for pancreas and islet cell transplantation. , 2010, World journal of gastroenterology.

[10]  T. Sakaguchi,et al.  Pathophysiological appraisal of a rat model of total hepatic ischemia with an extracorporeal portosystemic shunt. , 1998, The Journal of surgical research.

[11]  S. Fuggle,et al.  Ischemic Preconditioning of Cadaver Donor Livers Protects Allografts following Transplantation , 2006, Transplantation.

[12]  C. Herfarth,et al.  Oxygenated perfusion for liver preservation: a perfluorodecalin-UW emulsion is not feasible. , 1998, Transplantation proceedings.

[13]  Joan Roselló-Catafau,et al.  Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation. , 2006, Life sciences.

[14]  D. Sindram,et al.  Calpain inhibition prevents sinusoidal endothelial cell apoptosis in the cold ischemic rat liver. , 1999, Transplantation.

[15]  A. Tannapfel,et al.  Endothelin a receptor blockade reduces hepatic ischemia/reperfusion injury after warm ischemia in a pig model , 2003, Journal of Gastrointestinal Surgery.

[16]  J. Rodés,et al.  Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion , 2010, Cell Death and Disease.

[17]  P. Hasselgren,et al.  No beneficial effect of ATP-MgCl2 on impaired transmembrane potential and protein synthesis in liver ischemia. , 1982, Acta chirurgica Scandinavica.

[18]  G. Farrell,et al.  Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection , 2003, Journal of gastroenterology and hepatology.

[19]  H. Spiegel,et al.  Reduction of hepatic reperfusion injury by indomethacin-mediated vasoconstriction: a rat model with temporary splenocaval shunt. , 1995, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[20]  R. Bartrons,et al.  Adenosine monophosphate–activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia‐reperfusion injury in the rat , 2001, Hepatology.

[21]  S. Todo,et al.  Analogs of cyclic nucleotides in rat liver preservation. , 1998, Transplantation.

[22]  G. Gores,et al.  Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. , 1999, Transplantation.

[23]  K. Vekemans,et al.  Influence of flow and addition of oxygen during porcine liver hypothermic machine perfusion. , 2007, Transplantation proceedings.

[24]  R. Engemann Zur orthotopen Lebertransplantation bei der Ratte , 2004, Langenbecks Archiv für Chirurgie.

[25]  Hartmut Jaeschke,et al.  Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[26]  Zhi-gang Guo,et al.  Surgical techniques of arterialized orthotopic liver transplantation in rats. , 2007, Chinese medical journal.

[27]  A. Wetter,et al.  L-carnitine could not improve hepatic warm ischemia-reperfusion injury despite ameliorated blood flow. , 2005, The Journal of surgical research.

[28]  S. Yagi,et al.  Comprehensive and innovative techniques for liver transplantation in rats: a surgical guide. , 2010, World journal of gastroenterology.

[29]  M. Aller,et al.  The value of microsurgery in liver research , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[30]  H. Spiegel,et al.  Hepatic ischaemia–reperfusion injury from bench to bedside , 2010, The British journal of surgery.

[31]  A. Gasbarrini,et al.  Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. , 1998, Free radical biology & medicine.

[32]  E. Heineman,et al.  Short-term outcome of kidney transplants from non-heart-beating donors after preservation by machine perfusion , 1996 .

[33]  C. Murphy,et al.  Improved survival of orthotopic liver allograft in swine by addition of trophic factors to University of Wisconsin solution , 2004, Transplantation.

[34]  J. Roselló-Catafau,et al.  Activation of peroxisome proliferator‐activated receptor‐α inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia–reperfusion , 2007, Hepatology.

[35]  L. Grande,et al.  Preconditioning protects liver and lung damage in rat liver transplantation: Role of xanthine/xanthine oxidase , 2002, Hepatology.

[36]  M. Stadler,et al.  Effect of Nutritional Status on Oxidative Stress in an Ex Vivo Perfused Rat Liver , 2005, Anesthesiology.

[37]  H. Bismuth,et al.  Effects of 10 Minutes of Ischemic Preconditioning of the Cadaveric Liver on the Graft's Preservation and Function: The Ying and the Yang , 2005, Annals of surgery.

[38]  M. Ávila,et al.  The response of the hepatocyte to ischemia , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[39]  D. Palmes,et al.  Microsurgical training curriculum for learning kidney and liver transplantation in the rat , 2005, Microsurgery.

[40]  W. Helton Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. , 1993, JPEN. Journal of parenteral and enteral nutrition.

[41]  T. Kobayashi,et al.  Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation , 1996, Transplant international : official journal of the European Society for Organ Transplantation.

[42]  J. Roselló-Catafau,et al.  Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. , 1996, Biochemical and biophysical research communications.

[43]  A. O. Whipple,et al.  THE PROBLEM OF PORTAL HYPERTENSION IN RELATION TO THE HEPATOSPLENOPATHIES , 1945, Annals of surgery.

[44]  H. Jaeschke,et al.  Mitochondria and xanthine oxidase both generate reactive oxygen species in isolated perfused rat liver after hypoxic injury. , 1989, Biochemical and biophysical research communications.

[45]  K. Kohno,et al.  Alcoholic fatty liver differentially induces a neutrophil‐chemokine and hepatic necrosis after ischemia‐reperfusion in rat , 2000, Hepatology.

[46]  J. Sanabria,et al.  Effect of intraportal glucose infusion on hepatic glycogen content and degradation, and outcome of liver transplantation. , 1992, Annals of surgery.

[47]  H. Rüdiger,et al.  Mechanisms of ischemic injury are different in the steatotic and normal rat liver , 2000, Hepatology.

[48]  S. Matsumoto,et al.  Perfluorocarbon for organ preservation before transplantation. , 2002, Transplantation.

[49]  Inder M. Verma,et al.  Gene therapy: trials and tribulations , 2000, Nature Reviews Genetics.

[50]  J. Contreras,et al.  Caspase-8 and caspase-3 small interfering RNA decreases ischemia/reperfusion injury to the liver in mice. , 2004, Surgery.

[51]  A. Sckell,et al.  Adenosine deaminase inhibition attenuates reperfusion low flow and improves graft survival after rat liver transplantation. , 2000, Transplantation.

[52]  James G. Chandler,et al.  A TECHNIQUE FOR ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT , 1973, Transplantation.

[53]  F. Ramalho,et al.  Inhibition of angiotensin II action protects rat steatotic livers against ischemia-reperfusion injury , 2008, Critical care medicine.

[54]  J. Lakey,et al.  Preservation of the human pancreas before islet isolation using a two-layer (UW solution-perfluorochemical) cold storage method. , 2002, Transplantation.

[55]  Michael G. Schmidt,et al.  Fatty Acid Synthase Blockade Protects Steatotic Livers from Warm Ischemia Reperfusion Injury and Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[56]  N. Selzner,et al.  Protective strategies against ischemic injury of the liver. , 2003, Gastroenterology.

[57]  S. Bona,et al.  Liver ischemia for hepatic resection: where is the limit? , 1992, Surgery.

[58]  W. Burnett,et al.  Studies of hepatic response to changes in blood supply. , 1951, Surgical forum.

[59]  R. Calne,et al.  ORTHOTOPIC RAT LIVER TRANSPLANTATION AFTER LONG‐TERM PRESERVATION BY CONTINUOUS PERFUSION WITH FLUOROCARBON EMULSION , 1980, Transplantation.

[60]  P. Clavien,et al.  Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of interleukin‐6 , 1999, Hepatology.

[61]  T. Minor,et al.  Gaseous oxygen for hypothermic preservation of predamaged liver grafts: fuel to cellular homeostasis or radical tissue alteration? , 2000, Cryobiology.

[62]  H. Rüdiger,et al.  A Prospective Randomized Study in 100 Consecutive Patients Undergoing Major Liver Resection With Versus Without Ischemic Preconditioning , 2003, Annals of surgery.

[63]  M. Bernardi,et al.  Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[64]  C. Paidas,et al.  Susceptibility of hepatic microcirculation to reperfusion injury: a comparison of adult and suckling rats. , 1990, Journal of pediatric surgery.

[65]  J. Emond,et al.  Fifty-percent partial liver transplantation in the rat. , 1996, Transplantation.

[66]  A. Seifalian,et al.  Impairment of Hepatic Microcirculation in Fatty Liver , 2003, Microcirculation.

[67]  R. Busuttil,et al.  The utility of marginal donors in liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[68]  K. McMasters,et al.  Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury , 2000, Hepatology.

[69]  T. Bacchella,et al.  Protective effect of N2-mercaptopropionylglycine on rats and dogs liver during ischemia/reperfusion process. , 2003, Arquivos de gastroenterologia.

[70]  V. P. Chacko,et al.  Obesity Induces Expression of Uncoupling Protein-2 in Hepatocytes and Promotes Liver ATP Depletion* , 1999, The Journal of Biological Chemistry.

[71]  H. Harris,et al.  The Rat , 1958, Nature.

[72]  R. Schmidt Hepatic organ protection: from basic science to clinical practice. , 2010, World journal of gastroenterology.

[73]  赤堀 宇広 Importance of peroxisome proliferator-activated receptor-γ in hepatic ischemia/reperfusion injury in mice , 2008 .

[74]  A. Charters,et al.  Simplified technic for orthotopic liver transplantation in the rat. , 1975, American journal of surgery.

[75]  J. Rodés,et al.  Retinol-Binding Protein 4 and Peroxisome Proliferator-Activated Receptor-γ in Steatotic Liver Transplantation , 2011, Journal of Pharmacology and Experimental Therapeutics.

[76]  D. Wendum,et al.  Postischemic treatment by trans‐resveratrol in rat liver ischemia‐reperfusion: A possible strategy in liver surgery , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[77]  T. V. van Gulik,et al.  Seventy-two-hour preservation of the canine liver by machine perfusion. , 1990, Transplantation.

[78]  H. Wong,et al.  AGE-DEPENDENT RESPONSES TO HEPATIC ISCHEMIA/REPERFUSION INJURY , 2005, Shock.

[79]  P. Clavien,et al.  Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. , 1992, Transplantation.

[80]  R. Schuster,et al.  Activation of peroxisome proliferator-activated receptor-gamma during hepatic ischemia is age-dependent. , 2008, The Journal of surgical research.

[81]  P. Dionigi,et al.  A novel technique for rat liver transplantation using Quick Linker system: a preliminary result. , 2008, The Journal of surgical research.

[82]  R. Bartrons,et al.  Adenosine monophosphate-activated protein kinase and nitric oxide in rat steatotic liver transplantation. , 2005, Journal of hepatology.

[83]  J. Lemasters,et al.  Contribution of adenosine A2 receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers , 2000, Hepatology.

[84]  W. Chapman,et al.  Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[85]  J. Roselló-Catafau,et al.  Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion , 2004, Hepatology.

[86]  Joaquín V. Rodríguez,et al.  Effect of S-nitrosoglutathione (GSNO) added to the University of Wisconsin solution (UW): II) Functional response to cold preservation/reperfusion of rat liver. , 2002, Annals of hepatology.

[87]  S. Kapur,et al.  Glutathione supplementation during cold ischemia does not confer early functional advantage in renal transplantation. , 2000, Transplantation.

[88]  M. Sans,et al.  Preconditioning protects against systemic disorders associated with hepatic ischemia‐reperfusion through blockade of tumor necrosis factor–induced P‐selectin up‐regulation in the rat , 2001, Hepatology.

[89]  J. Engelhardt,et al.  Therapeutic approaches for ischemia/reperfusion injury in the liver , 1999, Journal of Molecular Medicine.

[90]  J. Roselló-Catafau,et al.  Ischemic preconditioning increases the tolerance of Fatty liver to hepatic ischemia-reperfusion injury in the rat. , 2002, The American journal of pathology.

[91]  I. Chaudry,et al.  Hepatic ischemia models for determining the effects of ATP-MgCl2 treatment. , 1986, The Journal of surgical research.

[92]  A. Gasbarrini,et al.  Gender Affects Reperfusion Injury in Rat Liver , 2001, Digestive Diseases and Sciences.

[93]  H. Mani,et al.  Use of a third-generation perfluorocarbon for preservation of rat DCD liver grafts. , 2012, The Journal of surgical research.

[94]  C. Herfarth,et al.  Definition of maximum cold ischemia time without reduction of graft quality in clinical liver transplantation. , 1998, Transplantation proceedings.

[95]  Y. Kuroda,et al.  [The effect of oxygen supply in continuous cold perfusion of the rat liver using perfluorochemical emulsion--parenchymal and nonparenchymal cell injuries evaluated with trypan blue perfusion/fixation techniques]. , 1993, Nihon Geka Gakkai zasshi.

[96]  M. Stegall,et al.  Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. , 1993, Transplantation.

[97]  F. Ramalho,et al.  Are Angiotensin II Receptor Antagonists Useful Strategies in Steatotic and Nonsteatotic Livers in Conditions of Partial Hepatectomy under Ischemia-Reperfusion? , 2009, Journal of Pharmacology and Experimental Therapeutics.

[98]  M. Manyalich,et al.  Liver Transplant Using Donors After Unexpected Cardiac Death: Novel Preservation Protocol and Acceptance Criteria , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[99]  R. Franco-Gou,et al.  Protection of Reduced‐Size Liver for Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[100]  R. Mason,et al.  Primary nonfunction of fatty livers produced by alcohol is associated with a new, antioxidant-insensitive free radical species. , 1995, Transplantation.

[101]  Takafumi Sato,et al.  A simple experimental model of total hepatectomy, hepatic ischemia and extrahepatic portal obstruction in rats using splenic transposition , 2006, The Japanese journal of surgery.

[102]  S. Fan,et al.  The influence of Phosphatidylinositol 3‐kinase/Akt Pathway on the Ischemic Injury during Rat Liver Graft Preservation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[103]  Shelly C. Lu,et al.  Non-alcoholic steatohepatitis and animal models: understanding the human disease. , 2009, The international journal of biochemistry & cell biology.

[104]  U. Mittmann,et al.  Postischemic liver damage in rats: effect of some therapeutic interventions on survival rate. , 1982, The Tohoku journal of experimental medicine.

[105]  Y. Abe,et al.  ROLE OF REACTIVE METABOLITES OF OXYGEN AND NITROGEN IN PARTIAL LIVER TRANSPLANTATION: LESSONS LEARNED FROM REDUCED‐SIZE LIVER ISCHAEMIA AND REPERFUSION INJURY , 2007, Clinical and experimental pharmacology & physiology.

[106]  C. Herfarth,et al.  Complement inhibition by soluble complement receptor type 1 improves microcirculation after rat liver transplantation. , 1998, Transplantation.

[107]  F. Trevisani,et al.  The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. , 2005, The Journal of surgical research.

[108]  P. Friend,et al.  Ex-vivo normothermic liver perfusion: an update , 2010, Current opinion in organ transplantation.

[109]  D. Palmes,et al.  Surgical techniques of orthotopic rat liver transplantation. , 1998, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[110]  M. Vairetti,et al.  Subnormothermic machine perfusion protects steatotic livers against preservation injury: A potential for donor pool increase? , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[111]  P. Clavien,et al.  ATP‐supplies in the cold‐preserved liver: A long‐neglected factor of organ viability , 2002, Hepatology.

[112]  M. Nicholson,et al.  The Role of Perfluorocarbon in Organ Preservation , 2010, Transplantation.

[113]  M. Menger,et al.  Improvement of rat liver graft quality by pifithrin‐α–mediated inhibition of hepatocyte necrapoptosis , 2004, Hepatology.

[114]  C. Fondevila,et al.  In-vivo normothermic recirculation: an update , 2010, Current opinion in organ transplantation.

[115]  A. Chong,et al.  Inactivation of kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts , 1995, Hepatology.

[116]  Xiu‐da Shen,et al.  Fibronectin-α4β1 Integrin-Mediated Blockade Protects Genetically Fat Zucker Rat Livers from Ischemia/Reperfusion Injury , 2003 .

[117]  Zhigang Tian,et al.  Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease , 2004, Hepatology.

[118]  N. Fausto,et al.  Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. , 2002, The Journal of clinical investigation.

[119]  R. Calne,et al.  ORTHOTOPIC LIVER TRANSPLANTATION IN THE RAT: TECHNIQUE USING CUFF FOR PORTAL VEIN ANASTOMOSIS AND BILIARY DRAINAGE , 1979, Transplantation.

[120]  L. Grande,et al.  Is Ischemic Preconditioning a Useful Strategy in Steatotic Liver Transplantation? , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[121]  H. Jaeschke,et al.  Mechanisms of reperfusion injury after warm ischemia of the liver. , 1998, Journal of hepato-biliary-pancreatic surgery.

[122]  Diethard Monbaliu,et al.  Machine perfusion of the liver: past, present and future , 2010, Current opinion in organ transplantation.

[123]  H. Schrem,et al.  Liver Transplantation After Organ Preservation With Normothermic Extracorporeal Perfusion , 2001, Annals of surgery.

[124]  S Bengmark,et al.  Subcutaneous transposition of the spleen--an experimental study in the rat. , 1970, Scandinavian journal of gastroenterology. Supplement.

[125]  J. Rodés,et al.  Therapeutic Targets in Liver Transplantation: Angiotensin II in Nonsteatotic Grafts and Angiotensin‐(1–7) in Steatotic Grafts , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[126]  A. Geerts,et al.  Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones , 2005, Alimentary pharmacology & therapeutics.

[127]  A. Boveris,et al.  Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. , 1993, The Journal of clinical investigation.

[128]  P. Clavien,et al.  Preconditioning, organ preservation, and postconditioning to prevent ischemia‐reperfusion injury to the liver , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.